IQVIA Holdings Inc (IQV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:IQVIA Holdings Inc (IQV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7244
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commercialization and technologies, and helps stimulate significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behaviors and scientific advances. IQVIA serves biotech, medical device and pharmaceutical companies; medical researchers, government agencies, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, the Middle East and Africa. IQVIA is headquartered in Durham, North Carolina, the US.

IQVIA Holdings Inc (IQV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IQVIA Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IQVIA Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IQVIA Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IQVIA Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
IQVIA Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
IQVIA Holdings Inc, Medical Equipment, Deal Details 10
Partnerships 10
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 10
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 11
Equity Offering 12
IQVIA Holdings Prices Secondary Offering of Shares for USD828 Million 12
Quintiles IMS Holdings Raises USD857.25 Million in Secondary Public Offering of Shares 14
Quintiles Transnational Completes IPO For US$525 Million 16
Acquisition 18
Quintiles Transnational Completes Acquisition of Encore Health Resources, Healthcare IT Company 18
Quintiles Transnational Completes Acquisition Of Novella Clinical Clinical Research Organization 19
Quintiles Acquires Minority Stake In Oxford Cancer Biomarkers For US$5 Million 20
IQVIA Holdings Inc – Key Competitors 21
IQVIA Holdings Inc – Key Employees 22
IQVIA Holdings Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 29
Recent Developments 31
Strategy And Business Planning 31
Sep 20, 2018: IQVIA to build clinically-focused tech solutions suite for life sciences on Salesforce health cloud 31
May 18, 2018: PruGen Pharmaceuticals Selects IQVIA’s OCE Technology Platform to Advance Field Sales and Home Office Effectiveness 32
Feb 06, 2018: IQVIA to Lead Group to Expand Safety/Efficacy Monitoring of Regulated Vaccines and Biologics for the FDA Center for Biologics Evaluation and Research 33
Financial Announcements 34
Jul 24, 2018: IQVIA Reports Second-Quarter 2018 Results and Raises Full-Year 2018 Revenue and Profit Guidance 34
May 18, 2018: IQVIA reaffirms Q2 and full-year 2018 guidance 36
Legal and Regulatory 37
May 16, 2018: FDA reports quality problems for data provided by the firm IQVIA that were used to inform estimates for some controlled substances 37
Product News 38
Jun 21, 2018: IQVIA Launches a Transformative Suite of Virtual Research Solutions 38
Jun 05, 2018: IQVIA Launches Commercial Content Management Solution IQVIA ePromo 39
Other Significant Developments 40
Apr 30, 2018: Recordati Selects IQVIA’s OCE Technology Platform and OneKey Information Services 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
IQVIA Holdings Inc, Medical Equipment, Key Facts, 2017 2
IQVIA Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
IQVIA Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IQVIA Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IQVIA Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IQVIA Holdings Inc, Deals By Market, 2012 to YTD 2018 8
IQVIA Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 10
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 11
IQVIA Holdings Prices Secondary Offering of Shares for USD828 Million 12
Quintiles IMS Holdings Raises USD857.25 Million in Secondary Public Offering of Shares 14
Quintiles Transnational Completes IPO For US$525 Million 16
Quintiles Transnational Completes Acquisition of Encore Health Resources, Healthcare IT Company 18
Quintiles Transnational Completes Acquisition Of Novella Clinical Clinical Research Organization 19
Quintiles Acquires Minority Stake In Oxford Cancer Biomarkers For US$5 Million 20
IQVIA Holdings Inc, Key Competitors 21
IQVIA Holdings Inc, Key Employees 22
IQVIA Holdings Inc, Other Locations 23
IQVIA Holdings Inc, Subsidiaries 23
IQVIA Holdings Inc, Joint Venture 29

List of Figures
IQVIA Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
IQVIA Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
IQVIA Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
IQVIA Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
IQVIA Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IQVIA Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
IQVIA Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IQVIA Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[IQVIA Holdings Inc (IQV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mega Uranium Ltd (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Gladstone Institutes:製薬・医療:M&Aディール及び事業提携情報
    Summary Gladstone Institutes (Gladstone) is a non-profit life science research organization that offers medical research programs. The organization carries out research and development in the areas of cardiovascular disease, virology and immunology, neurological disease, stem cell biology and regene …
  • Breko GmbH:企業の戦略・SWOT・財務分析
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nagacorp Ltd:企業の戦略・SWOT・財務情報
    Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report Summary Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • bet-at-home.com AG (ACX):企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務情報
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JTEKT Corp (6473):企業の財務・戦略的SWOT分析
    JTEKT Corp (6473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Icade SA:企業のM&A・事業提携・投資動向
    Icade SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icade SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Siliconware Precision Industries Co., Ltd.:企業の戦略的SWOT分析
    Siliconware Precision Industries Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Dermira Inc (DERM):製薬・医療:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Neenah Inc:企業の戦略・SWOT・財務情報
    Neenah Inc - Strategy, SWOT and Corporate Finance Report Summary Neenah Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hog’s Breath Cafe (Australia) Pty Ltd:企業の戦略・SWOT・財務情報
    Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Ubiquiti Networks Inc
    Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report Summary Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Decibel Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Decibel Therapeutics Inc (Decibel) is a hearing company that offers discovery, development and commercialization of new medicines for the treatment of hearing disorders. The company offer drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. It p …
  • Guerbet SA (GBT)-医療機器分野:企業M&A・提携分析
    Summary Guerbet SA (Guerbet) is a specialty pharmaceutical company which manufactures and markets medical imaging contrast agents destined for diagnostic purposes. The company provides a wide range of contrast agents for X-ray examinations and Magnetic Resonance Imaging (MRI). Guerbet also provides …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務情報
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Leadiant Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Leadiant Biosciences Inc (Leadiant Biosciences) a subsidiary of Sigma-Tau SpA is a pharmaceutical company that discovers and develops novel medicines. The company offers products such as Cystaran, Carnitor, Matulane, Adagen, Abelcet, DepoCyt, ProXeed Plus, VSL and Colief products. It offers …
  • LG Corp (003550):企業の財務・戦略的SWOT分析
    LG Corp (003550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆